文献速递血液淋巴病理

小样本活检诊断滤泡性淋巴瘤的诊断差异:多机构协作研究

Diagnostic Discrepancies in Small-volume Biopsy for the Initial Diagnosis, Recurrence, and Transformation of Follicular Lymphoma: A Multi-Institutional Collaborative Study.
PubMed 文献 · Am J Surg Pathol · 2022-12-20

本研究评估小样本活检(SVB)在滤泡性淋巴瘤(FL)初始诊断、复发或转化中的诊断性能,纳入5年内182例有后续活检的病例。后续活检最常见结果为更具体诊断(61%),完全一致13%,非诊断转为诊断12%;少数从良性变为淋巴瘤9%,FL分级改变3%,淋巴瘤类别改变2%;无初始淋巴瘤诊断被推翻。组织限制见于29%病例。

要点

  • SVB诊断FL时,多数差异源于后续活检对初始诊断的细化(如明确分级)。
  • 初始淋巴瘤诊断未被推翻,提示SVB诊断淋巴瘤可靠。
  • 组织限制在初始非诊断病例中更常见(76%)。

核心结论

  • SVB是检测FL的有效方法,差异病例多源于初始诊断的细化。

研究设计与样本

  • 多机构协作研究,回顾性分析5年内因FL初始诊断、复发或转化行SVB且有后续活检的连续病例,最终纳入182例。

主要发现

  • 后续活检更具体诊断111/182(61%),完全一致24/182(13%),非诊断转诊断21/182(12%),良性转淋巴瘤17/182(9%),FL分级改变5/182(3%),淋巴瘤类别改变4/182(2%)。
  • 无初始淋巴瘤诊断被推翻的病例。
  • 组织限制53/182(29%),在初始非诊断病例中占16/21(76%)。
  • 流式细胞免疫分型在首次和末次活检中均进行147/182(81%)。

临床怎么用

  • SVB可用于FL初始诊断、复发和转化的评估,但需注意组织限制可能导致非诊断。
  • 当SVB结果不明确时,建议结合后续活检以明确分级和诊断。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Small-volume biopsies (SVBs) including fine-needle aspiration (FNA), cell block, and needle core biopsies (NCB) are increasingly utilized to diagnose and guide the clinical management of lymphoma. We established a multi-institutional interdisciplinary collaboration of cytopathologists, hematopathologists, and oncologists focused on the role of SVB in the management of patients with follicular lymphoma (FL). To assess the performance characteristics of SVB in this setting, we evaluated all consecutive SVBs performed for clinical indications of initial diagnosis, recurrence, or transformation of FL over a 5-year period and focused on the 182 that had at least one subsequent biopsy within 3 months as part of the same clinical work-up. The most common outcome of a subsequent biopsy as part of the same clinical work-up was a more specific diagnosis usually assigning the pathologic grade (111/182, 61%), followed by a complete agreement with the SVB (24/182, 13%), and change from nondiagnostic on initial biopsy to diagnostic on subsequent biopsy (21/182, 12%). A minority resulted in a diagnostic change from benign to lymphoma (17/182, 9%), a change in FL grade (5/182, 3%), or change in the lymphoma diagnostic category (4/182, 2%). There were no cases where an initial diagnosis of lymphoma was overturned. The distribution of discrepancies was similar across initial SVB types (FNA, FNA + cell block, NCB with or without FNA). Tissue limitations were noted in a minority of cases (53/182, 29%) and were enriched among initially nondiagnostic biopsies (16/21, 76%). Flow cytometry immunophenotyping was performed in the majority of cases both at the first and last biopsy (147/182, 81%). SVB can be a powerful method to detect FL in various clinical indications, with discrepant cases mostly resulting from a refinement in the initial diagnosis.

来源:Am J Surg Pathol,查看原文。版权归原作者所有。

引用

  1. Volaric AK, Lin O, Balassanian R, et al. Diagnostic Discrepancies in Small-volume Biopsy for the Initial Diagnosis, Recurrence, and Transformation of Follicular Lymphoma: A Multi-Institutional Collaborative Study. Am J Surg Pathol. 2022. PMID: 36537240. doi:10.1097/PAS.0000000000001985

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。